The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
The Novel Tuberculosis Vaccine, AERAS-402, Induces Robust and Polyfunctional CD4 + and CD8 + T Cells in Adults
Open accessAbstract
RATIONALE: AERAS-402 is a novel tuberculosis vaccine designed to boost immunity primed by bacillus Calmette-Guérin (BCG), the only licensed vaccine. OBJECTIVES: We investigated the safety and immunogenicity of AERAS-402 in healthy Mycobacterium tuberculosis-uninfected BCG-vaccinated adults from a tuberculosis-endemic region of South Africa. METHODS: Escalating doses of AERAS-402 vaccine were administered intramuscularly to each of three groups of healthy South African BCG-vaccinated adults, and a fourth group received two injections of the maximal dose. Participants were monitored for 6 months, with all adverse effects documented. Vaccine-induced CD4(+) and CD8(+) T-cell immunity was characterized by an intracellular cytokine staining assay of whole blood and peripheral blood mononuclear cells. MEASUREMENTS AND MAIN RESULTS: AERAS-402 was well tolerated, and no vaccine-related serious adverse events were recorded. The vaccine induced a robust CD4(+) T-cell response dominated by cells coexpressing IFN-gamma, tumor necrosis factor-alpha, and IL-2 ("polyfunctional" cells). AERAS-402 also induced a potent CD8(+) T-cell response, characterized by cells expressing IFN-gamma and/or tumor necrosis factor-alpha, which persisted for the duration of the study. CONCLUSIONS: Vaccination with AERAS-402 is safe and immunogenic in healthy adults. The immunity induced by the vaccine appears promising: polyfunctional T cells are thought to be important for protection against intracellular pathogens such as Mycobacterium tuberculosis, and evidence is accumulating that CD8(+) T cells are also important. AERAS-402 induced a robust and durable CD8(+) T-cell response, which appears extremely promising. Clinical trial registered with www.sanctr.gov.za (NHREC no. 1381).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Apoptotic Vesicles Crossprime CD8 T Cells and Protect against Tuberculosis
Winau, F., Weber, S., Sad, S., de Diego, J., Hoops, S. L., Breiden, B., Sandhoff, K., Brinkmann, V., Kaufmann, S. H. E., & Schaible, U. E. (2006) · Immunity · doi:10.1016/j.immuni.2005.12.001 · Cited by 395
Cited by
Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19
Su, Y., Chen, D., Yuan, D., Lausted, C., Choi, J., Dai, C. L., Voillet, V., Duvvuri, V. R., Scherler, K., Troisch, P., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.037 · Cited by 589
Immunological biomarkers of tuberculosis
Walzl, G., Ronacher, K., Hanekom, W., Scriba, T. J., & Zumla, A. (2011) · Nature Reviews Immunology · doi:10.1038/nri2960 · Cited by 477
Self-citationVaccines against Tuberculosis: Where Are We and Where Do We Need to Go?
Ottenhoff, T. H. M., & Kaufmann, S. H. E. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002607 · Cited by 455
Kagina, B. M. N., Abel, B., Scriba, T. J., Hughes, E. J., Keyser, A., Soares, A., Gamieldien, H., Sidibana, M., Hatherill, M., Gelderbloem, S., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201003-0334oc · Cited by 402
Self-citationT cells and adaptive immunity to Mycobacterium tuberculosis in humans
Jasenosky, L. D., Scriba, T. J., Hanekom, W. A., & Goldfeld, A. E. (2015) · Immunological Reviews · doi:10.1111/imr.12274 · Cited by 362
Self-citation
Metadata
- Authors
- Abel, B., Tameris, M., Mansoor, N., Gelderbloem, S., Hughes, J., Abrahams, D., Makhethe, L., Erasmus, M., Kock, M. D., van der Merwe, L., Hawkridge, A., Veldsman, A., Hatherill, M., Schirru, G., Pau, M. G., Hendriks, J., Weverling, G. J., Goudsmit, J., Sizemore, D., McClain, J. B., Goetz, M., Gearhart, J., Mahomed, H., Hussey, G. D., Sadoff, J. C., & Hanekom, W. A.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-06-15
- Volume
- 181
- Issue
- 12
- Pages
- 1407-1417
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2040780498
- Cited by
- 227
- References
- 1
- FWCI
- 16.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Novel Tuberculosis Vaccine, AERAS-402, Induces Robust and Polyfunctional CD4 + and CD8 + T Cells in Adults. https://app.cochat.ai/papers/10.1164/rccm.200910-1484oc
- The paper
- Abel, B., Tameris, M., Mansoor, N., Gelderbloem, S., Hughes, J., Abrahams, D., Makhethe, L., Erasmus, M., Kock, M. D., van der Merwe, L., Hawkridge, A., Veldsman, A., Hatherill, M., Schirru, G., Pau, M. G., Hendriks, J., Weverling, G. J., Goudsmit, J., Sizemore, D., . . . Hanekom, W. A. (2010). The Novel Tuberculosis Vaccine, AERAS-402, Induces Robust and Polyfunctional CD4 + and CD8 + T Cells in Adults. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.200910-1484oc
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.